Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Differential pattern of Doppler signals at lower-extremity entheses of healthy children.

Roth J, Stinson SE, Chan J, Barrowman N, Di Geso L.

Pediatr Radiol. 2019 Sep;49(10):1335-1343. doi: 10.1007/s00247-019-04464-8. Epub 2019 Jul 9.

PMID:
31289909
2.

Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS.

Kitajima S, Asahina H, Chen T, Guo S, Quiceno LG, Cavanaugh JD, Merlino AA, Tange S, Terai H, Kim JW, Wang X, Zhou S, Xu M, Wang S, Zhu Z, Thai TC, Takahashi C, Wang Y, Neve R, Stinson S, Tamayo P, Watanabe H, Kirschmeier PT, Wong KK, Barbie DA.

Cancer Cell. 2018 Sep 10;34(3):439-452.e6. doi: 10.1016/j.ccell.2018.08.009.

3.

The South Carolina Surgical Quality Collaborative: A New Effort to Improve Surgical Outcomes in South Carolina.

Lockett MA, Turley C, Gibbons L, Stinson S, Adams JL, Cole D, Baliga PK.

Am Surg. 2018 Jun 1;84(6):916-919.

PMID:
29981624
4.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

5.

Evidence-Based Practice: Video-Discharge Instructions in the Pediatric Emergency Department.

Wood EB, Harrison G, Trickey A, Friesen MA, Stinson S, Rovelli E, McReynolds S, Presgrave K.

J Emerg Nurs. 2017 Jul;43(4):316-321. doi: 10.1016/j.jen.2016.11.003. Epub 2017 Mar 28.

PMID:
28359707
6.

Genomic Tools for Customized Recovery and Detection of Foodborne Shiga Toxigenic Escherichia coli.

Knowles M, Stinson S, Lambert D, Carrillo C, Koziol A, Gauthier M, Blais B.

J Food Prot. 2016 Dec;79(12):2066-2077. doi: 10.4315/0362-028X.JFP-16-220.

PMID:
28221970
7.

Are the Conclusions of Z11 Relevant to Community Practice?

Jones GC, Dong T, Simone CB 2nd, Stinson S.

Clin Breast Cancer. 2015 Aug;15(4):285-8. doi: 10.1016/j.clbc.2014.12.013. Epub 2015 Jan 7.

8.

D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells.

Stinson SE, Amrani Y, Brightling CE.

J Allergy Clin Immunol. 2015 Feb;135(2):395-406. doi: 10.1016/j.jaci.2014.08.027. Epub 2014 Oct 11.

9.

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.

Weisser M, Yeh RF, Duchateau-Nguyen G, Palermo G, Nguyen TQ, Shi X, Stinson SY, Yu N, Dufour A, Robak T, Salogub GN, Dmoszynska A, Solal-Celigny P, Warzocha K, Loscertales J, Catalano J, Larratt L, Rossiev VA, Bence-Bruckler I, Geisler CH, Montillo M, Fischer K, Fink AM, Hallek M, Bloehdorn J, Busch R, Benner A, Döhner H, Valente N, Wenger MK, Stilgenbauer S, Dornan D.

Blood. 2014 Jul 17;124(3):420-5. doi: 10.1182/blood-2013-12-538975. Epub 2014 Jun 10.

10.

miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.

Hwang MS, Yu N, Stinson SY, Yue P, Newman RJ, Allan BB, Dornan D.

PLoS One. 2013 Jun 11;8(6):e66502. doi: 10.1371/journal.pone.0066502. Print 2013.

11.

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.

Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D.

Sci Signal. 2011 Aug 9;4(186):pt5. doi: 10.1126/scisignal.2002258.

PMID:
21868360
12.

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.

Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh RF, Dornan D.

Sci Signal. 2011 Jun 14;4(177):ra41. doi: 10.1126/scisignal.2001538.

13.

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.

Burington B, Yue P, Shi X, Advani R, Lau JT, Tan J, Stinson S, Stinson J, Januario T, de Vos S, Ansell S, Forero-Torres A, Fedorowicz G, Yang TT, Elkins K, Du C, Mohan S, Yu N, Modrusan Z, Seshagiri S, Yu SF, Pandita A, Koeppen H, French D, Polson AG, Offringa R, Whiting N, Ebens A, Dornan D.

Sci Transl Med. 2011 Mar 16;3(74):74ra22. doi: 10.1126/scitranslmed.3001620.

14.

RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.

DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A, Mi S, Yam P, Stinson S, Kalos M, Alvarnas J, Lacey SF, Yee JK, Li M, Couture L, Hsu D, Forman SJ, Rossi JJ, Zaia JA.

Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931.

15.

Airway wall expression of OX40/OX40L and interleukin-4 in asthma.

Siddiqui S, Mistry V, Doe C, Stinson S, Foster M, Brightling C.

Chest. 2010 Apr;137(4):797-804. doi: 10.1378/chest.09-1839. Epub 2010 Feb 5.

16.

Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.

Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):468-76. doi: 10.1016/j.ijrobp.2009.05.018. Epub 2009 Jul 4.

PMID:
19577867
17.

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

Qing J, Du X, Chen Y, Chan P, Li H, Wu P, Marsters S, Stawicki S, Tien J, Totpal K, Ross S, Stinson S, Dornan D, French D, Wang QR, Stephan JP, Wu Y, Wiesmann C, Ashkenazi A.

J Clin Invest. 2009 May;119(5):1216-29. doi: 10.1172/JCI38017. Epub 2009 Apr 20.

18.

Nutritional, developmental, and genetic influences on relative sitting height at high altitude.

Stinson S.

Am J Hum Biol. 2009 Sep-Oct;21(5):606-13. doi: 10.1002/ajhb.20918.

PMID:
19322886
19.

The future of RN practice in Alberta.

Stinson S.

Alta RN. 2008 Sep;64(7):25. No abstract available.

PMID:
18942488
20.

Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).

Hariprakasha HK, Kosakowska-Cholody T, Meyer C, Cholody WM, Stinson SF, Tarasova NI, Michejda CJ.

J Med Chem. 2007 Nov 15;50(23):5557-60. Epub 2007 Oct 16.

PMID:
17939651
21.

Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.

Sadaghiani AM, Verhelst SH, Gocheva V, Hill K, Majerova E, Stinson S, Joyce JA, Bogyo M.

Chem Biol. 2007 May;14(5):499-511.

22.

Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.

Brantley E, Antony S, Kohlhagen G, Meng L, Agama K, Stinson SF, Sausville EA, Pommier Y.

Cancer Chemother Pharmacol. 2006 Jul;58(1):62-72. Epub 2005 Dec 6.

PMID:
16331501
23.

Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.

Li M, Wang H, Hill DL, Stinson S, Veley K, Grossi I, Peggins J, Covey JM, Zhang R.

Cancer Chemother Pharmacol. 2006 May;57(5):607-14. Epub 2005 Dec 6.

PMID:
16331493
24.

Nursing excellence by design. Interview by Barbara Sibbald.

Stinson S.

Can Nurse. 2005 Oct;101(8):42-4. No abstract available.

PMID:
16295366
25.

Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs.

Kaur G, Narayanan VL, Risbood PA, Hollingshead MG, Stinson SF, Varma RK, Sausville EA.

Bioorg Med Chem. 2005 Mar 1;13(5):1749-61.

PMID:
15698792
26.

The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells.

Brantley E, Patel V, Stinson SF, Trapani V, Hose CD, Ciolino HP, Yeh GC, Gutkind JS, Sausville EA, Loaiza-Pérez AI.

Anticancer Drugs. 2005 Feb;16(2):137-43.

PMID:
15655410
27.

Poly(ethylene glycol) prodrugs of the CDK inhibitor, alsterpaullone (NSC 705701): synthesis and pharmacokinetic studies.

Greenwald RB, Zhao H, Xia J, Wu D, Nervi S, Stinson SF, Majerova E, Bramhall C, Zaharevitz DW.

Bioconjug Chem. 2004 Sep-Oct;15(5):1076-83.

PMID:
15366962
28.

Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.

Brantley E, Trapani V, Alley MC, Hose CD, Bradshaw TD, Stevens MF, Sausville EA, Stinson SF.

Drug Metab Dispos. 2004 Dec;32(12):1392-401. Epub 2004 Sep 8.

PMID:
15355884
29.

Creating a successful clinical extern program using a program planning logic model.

Stinson S, Wilkinson C.

J Nurses Staff Dev. 2004 May-Jun;20(3):140-4.

PMID:
15201835
30.

17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models.

Burger AM, Fiebig HH, Stinson SF, Sausville EA.

Anticancer Drugs. 2004 Apr;15(4):377-87.

PMID:
15057143
31.

Clinical pharmacology of flavopiridol following a 72-hour continuous infusion.

Rudek MA, Bauer KS Jr, Lush RM 3rd, Stinson SF, Senderowicz AM, Headlee DJ, Arbuck SG, Cox MC, Murgo AJ, Sausville EA, Figg WD.

Ann Pharmacother. 2003 Oct;37(10):1369-74.

PMID:
14519054
32.

Participation of women in human biology, 1975-2001.

Stinson S.

Am J Hum Biol. 2003 May-Jun;15(3):440-5.

PMID:
12704720
33.

Self-measurement and ambulatory monitoring of blood pressure: a subject's chronobiological perspective.

Stinson SM, Cornélissen G, Scarpelli PT, Halberg F.

Biomed Pharmacother. 2002;56 Suppl 2:333s-338s.

PMID:
12653189
34.

SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.

Panasci L, Stinson SF, Melnychuk D, Sandor V, Miller WH Jr, Batist G, Patenaude F, Bangash N, Panarello L, Alaoui-Jamali M, Sausville E.

J Clin Oncol. 2003 Jan 15;21(2):232-40.

PMID:
12525514
35.

Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.

Bradshaw TD, Bibby MC, Double JA, Fichtner I, Cooper PA, Alley MC, Donohue S, Stinson SF, Tomaszewjski JE, Sausville EA, Stevens MF.

Mol Cancer Ther. 2002 Feb;1(4):239-46. Erratum in: Mol Cancer Ther. 2003 Feb;2(2):207.

36.

Shirley Stinson. Interview by Anne J. Davis.

Stinson S.

Nurs Ethics. 2002 Jul;9(4):342-6. No abstract available.

PMID:
12219398
37.

Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse.

Stinson SF, House T, Bramhall C, Saavedra JE, Keefer LK, Nims RW.

Xenobiotica. 2002 Apr;32(4):339-47.

PMID:
12028666
38.

Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline.

Safdar A, Bryan CS, Stinson S, Saunders DE.

Clin Infect Dis. 2002 Jun 1;34(11):E61-3. Epub 2002 May 9.

PMID:
12015709
39.

Excellence in forensic practice: a clinical ladder model for recruiting and retaining sexual assault nurse examiners (SANEs).

Sievers V, Stinson S.

J Emerg Nurs. 2002 Apr;28(2):172-5. No abstract available.

PMID:
11960135
40.

Identification of the major metabolite of 2,5-bis(5-hydroxymethyl-2-thienyl)furan (NSC 652287), an antitumor agent, in the S9 subcellular fraction of dog liver cells.

Phillip LR, Jorden JL, Rivera MI, Wolfe TL, Upadhyayb K, Stinson SF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 5;767(1):27-33.

PMID:
11863292
41.

Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

Chua MS, Kashiyama E, Bradshaw TD, Stinson SF, Brantley E, Sausville EA, Stevens MF.

Cancer Res. 2000 Sep 15;60(18):5196-203.

42.

Identification of the principal circulating metabolite of a synthetic 5,4'-diaminoflavone (NSC 686288), an antitumor agent, in the rat.

Phillips LR, Bramhall C, Buckley J, Wolfe T, House TL, Stinson SF.

J Chromatogr B Biomed Sci Appl. 2000 May 12;741(2):205-11.

PMID:
10872590
43.

Analysis of 2-(3-methyl-4-aminophenyl)-benzothiazole (NSC 674495) in plasma by gas chromatography with mass-selective detection.

Phillips LR, Bramhall C, Buckley J, Daw TW, Stinson SF.

J Chromatogr B Biomed Sci Appl. 1999 Sep 24;732(2):315-21.

PMID:
10517353
44.

Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.

Kashiyama E, Hutchinson I, Chua MS, Stinson SF, Phillips LR, Kaur G, Sausville EA, Bradshaw TD, Westwell AD, Stevens MF.

J Med Chem. 1999 Oct 7;42(20):4172-84.

PMID:
10514287
45.

Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target.

Sausville EA, Zaharevitz D, Gussio R, Meijer L, Louarn-Leost M, Kunick C, Schultz R, Lahusen T, Headlee D, Stinson S, Arbuck SG, Senderowicz A.

Pharmacol Ther. 1999 May-Jun;82(2-3):285-92. Review.

PMID:
10454206
46.

Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein.

Schnier JB, Kaur G, Kaiser A, Stinson SF, Sausville EA, Gardner J, Nishi K, Bradbury EM, Senderowicz AM.

FEBS Lett. 1999 Jul 2;454(1-2):100-4.

47.

Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: differential accumulation and metabolism.

Rivera MI, Stinson SF, Vistica DT, Jorden JL, Kenney S, Sausville EA.

Biochem Pharmacol. 1999 Jun 1;57(11):1283-95.

PMID:
10230772
48.

Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2' ligand.

Randad RS, Lubkowska L, Eissenstat MA, Gulnik SV, Yu B, Bhat TN, Clanton DJ, House T, Stinson SF, Erickson JW.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3537-42.

PMID:
9934467
49.

Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection.

Stinson SF, Hill K, Siford TJ, Phillips LR, Daw TW.

Cancer Chemother Pharmacol. 1998;42(4):261-5.

PMID:
9744769
50.

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG, Sausville EA.

J Clin Oncol. 1998 Sep;16(9):2986-99.

PMID:
9738567

Supplemental Content

Loading ...
Support Center